These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24008841)

  • 1. No-reflow reversibility: a study based on serial assessment of multiple biomarkers.
    Niccoli G; Fracassi F; Cosentino N; Falcioni E; Roberto M; De Luca G; Leone AM; Burzotta F; Porto I; Trani C; Severino A; Crea F
    J Cardiovasc Transl Res; 2013 Oct; 6(5):798-807. PubMed ID: 24008841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
    Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
    Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
    Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.
    Cuculi F; Herring N; De Caterina AR; Banning AP; Prendergast BD; Forfar JC; Choudhury RP; Channon KM; Kharbanda RK
    Heart; 2013 Aug; 99(16):1198-203. PubMed ID: 23403409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aitmokhtar O; Paganelli F; Benamara S; Azaza A; Bonello L; Hamza O; Seddiki S; Benathmane T; Saidane M; Bouzid A; Kara M; Sik A; Azzouz A; Harbi F; Monsuez JJ; Benkhedda S
    Arch Cardiovasc Dis; 2017 Nov; 110(11):626-633. PubMed ID: 28583820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between circulating miRNA-30e and no-reflow phenomenon in STEMI patients undergoing primary coronary intervention.
    Su Q; Ye Z; Sun Y; Yang H; Li L
    Scand J Clin Lab Invest; 2018 Jul; 78(4):318-324. PubMed ID: 29703083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
    Kurtul A; Acikgoz SK
    Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History.
    Gao R; Wang J; Zhang S; Yang G; Gao Z; Chen X
    Med Sci Monit; 2018 May; 24():3549-3556. PubMed ID: 29806659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome c release in acute myocardial infarction predicts poor prognosis and myocardial reperfusion on contrast-enhanced magnetic resonance imaging.
    Liu ZB; Fu XH; Wei G; Gao JL
    Coron Artery Dis; 2014 Jan; 25(1):66-72. PubMed ID: 24077325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Quisi A; Alıcı G
    J Clin Lab Anal; 2018 Nov; 32(9):e22598. PubMed ID: 29943408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality.
    Del Turco S; Basta G; De Caterina AR; Sbrana S; Paradossi U; Taddei A; Trianni G; Ravani M; Palmieri C; Berti S; Mazzone A
    Int J Cardiol; 2019 Sep; 290():34-39. PubMed ID: 31079969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
    Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
    Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of lesion complexity on no-reflow phenomenon and predictors of reversibility in patients treated with primary percutaneous intervention.
    Durmaz E; Karadag B; Ikitimur B; Atici A; Koca D; Mutlu D; Soysal AU; Raimoglu U; Ozmen E; Ohtaroglu Tokdil K; Incesu G; Ongen Z
    Coron Artery Dis; 2020 Dec; 31(8):678-686. PubMed ID: 32271241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
    Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention.
    Tang L; Fang ZF; Zhou SH; Tai S; Ahmed S; Huang F; Shen XQ; Zhao YS; Hu XQ
    Heart Vessels; 2016 Sep; 31(9):1456-66. PubMed ID: 26498756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Importance of Magnesium Values in Patients With STEMI Admitted to the Emergency Department.
    Yuksel M; Isik T; Tanboga IH; Ayhan E; Erimsah ME; Topcu S; Demirelli S; Aksakal E; Sevimli S
    Clin Appl Thromb Hemost; 2017 May; 23(4):329-335. PubMed ID: 27418637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.